Biocon Ltd
NSE:BIOCON
Biocon Ltd
NSE:BIOCON
Price:
315.5 INR
2.45%
Market Closed
Updated:
May 24, 2024
Biocon Ltd
Gross Profit
|
Biocon Ltd
Gross Profit Peer Comparison
Comparables:
524663
526139
Z
532039
HESTERBIO
PANACEABIO
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biocon Ltd
NSE:BIOCON
|
Gross Profit
₹98.2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
25%
|
CAGR 10-Years
20%
|
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Gross Profit
-₹141.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
|
Transgene Biotek Ltd
BSE:526139
|
Gross Profit
-₹112.3k
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Gross Profit
₹2.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Gross Profit
₹1.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
See Also
What is Biocon Ltd's Gross Profit?
Gross Profit
98.2B
INR
98.2B
INR
Based on the financial report for Dec 31, 2023, Biocon Ltd's Gross Profit amounts to 98.2B INR.
What is Biocon Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
20%
20%
Over the last year, the Gross Profit growth was 50%. The average annual Gross Profit growth rates for Biocon Ltd have been 28% over the past three years , 25% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
